门诊上消化道内镜检查患者使用胰高血糖素样肽-1受体激动剂相关的内镜与麻醉结局
这项单中心回顾性队列研究纳入598例门诊内镜患者,比较使用胰高血糖素样肽-1受体激动剂(GLP-1RA)≥6周者与对照者的结局。GLP-1RA组固体胃残留内容物风险升高(OR 3.80),中止操作更多(1.3% vs 0%),但缺氧率相似,无肺误吸病例。
要点
- GLP-1RA组固体胃残留内容物风险升高(OR 3.80;95%CI 1.57-9.21;P=.003)。
- 同期行结肠镜检查者固体胃残留内容物风险未见升高。
- GLP-1RA组操作中止率更高(1.3% vs 0%;P=.021),缺氧率相似。
核心结论
- 服用GLP-1RA的患者上消化道内镜检查时固体胃残留内容物发生率升高(同期结肠镜检查者除外),操作中止率更高,但麻醉不良事件发生率相似。
研究设计与样本
- 单中心回顾性队列研究,纳入598例门诊内镜患者,GLP-1RA组360例(经药房发药报告确认暴露≥6周),对照组298例(未服用GLP-1RA)。
主要发现
- GLP-1RA组糖尿病患病率更高(68% vs 57%;P=.005)。
- 多因素分析显示GLP-1RA组固体胃残留内容物风险显著升高(OR 3.80;95%CI 1.57-9.21;P=.003)。
- 同期行结肠镜检查的患者中固体胃残留内容物风险未升高。
- GLP-1RA组操作中止率更高(1.3% vs 0%;P=.021)。
- 两组缺氧率相似(0.2% vs 0.3%;P=.341),无肺误吸病例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) can cause delayed gastric emptying, raising concern for retained gastric contents (RGC) during endoscopy and adverse anesthesia events. The aim of this study was to determine associations between GLP-1RA and endoscopy and anesthesia outcomes. METHODS: This single-center, retrospective cohort study examined patients prescribed GLP-1RAs who underwent outpatient endoscopy stratified according to exposure at the time of endoscopy. The GLP-1RA group had ≥6 weeks of exposure as confirmed by pharmacy dispensation reports. The control group were patients not taking GLP-1RAs at the time of endoscopy (prescription never filled, discontinued ≥6 weeks prior, or started postendoscopy). The outcomes were the presence of solid RGC, aborted procedures, or any adverse anesthesia events. RESULTS: A total of 598 patients were included in the study; 360 were taking GLP-1RAs, and 298 were control subjects. Baseline characteristics, including age, sex, chronic opiate use, gastroparesis, and prior gastric surgery, were similar, but diabetes mellitus was more prevalent in the GLP-1RA group (68% vs 57%; P = .005). The odds of solid RGC was significantly higher in the GLP-1RA group in multivariate analysis (odds ratio, 3.80; 95% confidence interval, 1.57-9.21; P = .003), but odds were not increased in patients undergoing concurrent colonoscopy. More patients in the GLP-1RA group had procedures aborted (1.3% vs 0%; P = .021), but rates of hypoxia were similar (.2% vs .3%; P = .341). There were no cases of pulmonary aspiration. CONCLUSIONS: Patients taking GLP-1RAs have increased rates of solid RGC during upper endoscopy (but not with concurrent colonoscopy) and higher rates of aborted procedures but similar rates of adverse anesthesia events.
引用
- Panchal S, Mahmud N, Atkins JH, et al. Endoscopy and anesthesia outcomes associated with glucagon-like peptide-1 receptor agonist use in patients undergoing outpatient upper endoscopy. Gastrointest Endosc. 2025. PMID: 39824444. doi:10.1016/j.gie.2025.01.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。